Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for Q9982. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
13
Median % of Medicare
--
Rate range
$989.33 - $4,258.34
Q9982 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Arkansas | $1,846.81* | -- | -- | 2026 |
| Arizona | $2,845.58 | -- | -- | 2026 |
| Colorado | $3,724.76 | -- | -- | 2026 |
| Iowa | $3,342.24 | -- | -- | 2024 |
| Kentucky | $1,944.01 | -- | -- | 2026 |
| Michigan | $1,016.72 | -- | -- | 2026 |
| Missouri | $1,749.61 | -- | Not required | 2026 |
| Montana | $1,944.01 | -- | -- | 2026 |
| New Hampshire | $2,826.66 | -- | Not required | 2026 |
| New Mexico | $989.33 | -- | -- | 2026 |
| Oklahoma | $1,713.48 | -- | -- | 2026 |
| Rhode Island | $4,258.34 | -- | -- | 2026 |
| South Carolina | $3,148.80 | -- | -- | 2026 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related state-specific services codes
- C1716 - Brachytherapy source, non-stranded, gold-198, per source
- C1717 - Brachytherapy source, non-stranded, high dose rate iridium-192, per source
- C1719 - Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source
- C2616 - Brachytherapy source, non-stranded, yttrium-90, per source
- C2634 - Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source
- C2635 - Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source
- C2636 - Brachytherapy linear source, non-stranded, palladium-103, per 1 mm
- C2638 - Brachytherapy source, stranded, iodine-125, per source
All 22 codes from Q9950 to Q9999 or every state-specific services code by number.
Frequently asked questions
How much does Medicaid pay for Q9982?
13 state Medicaid programs publish a fee-for-service rate for Q9982 (flutemetamol f18, diagnostic, per study dose, up to 5 millicuries), ranging from $989.33 in New Mexico to $4,258.34 in Rhode Island. The full table on this page lists every publishing state's current rate.
Which state pays the most for Q9982?
Rhode Island publishes the highest Medicaid rate for Q9982 at $4,258.34. New Mexico publishes the lowest at $989.33.
Does Q9982 require prior authorization under Medicaid?
No publishing state flags Q9982 with a prior-authorization indicator on its fee schedule. Absence of a flag means the state publishes none, not that PA is never required - confirm through the state's provider manual.